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ABSTRACT
Objective: We investigated the prevalence and clinical-radiologic associations of cortical superficial
siderosis (cSS) in patients with probable cerebral amyloid angiopathy (CAA) compared to those with
intracerebral hemorrhage (ICH) not attributed to CAA.
Methods: We conducted a retrospective multicenter cohort study of 120 patients with probable
CAA and 2 comparison groups: 67 patients with either single lobar ICH or mixed (deep and lobar)
hemorrhages; and 22 patients with strictly deep hemorrhages. We rated cSS, ICH, white matter
changes, and cerebral microbleeds.
Results: cSSwas detected in 48 of 120 (40%; 95% confidence interval [CI]: 31.2%–49.3%) patients
with probable CAA, 10 of 67 (14.9%; 95% CI: 7.4%–25.7%) with single lobar ICH or mixed hemor-
rhages, and1of 22 (4.6%;95%CI: 0.1%–22.8%) patientswith strictly deep hemorrhages (p, 0.001
for trend). Disseminated cSS was present in 29 of 120 (24%; 95% CI: 16.8%–32.8%) patients with
probable CAA, but none of the other patients with ICH (p , 0.001). In probable CAA, age (odds ratio
[OR]: 1.09; 95% CI: 1.03–1.15; p 5 0.002), chronic lobar ICH (OR: 3.94; 95% CI: 1.54–10.08; p 5
0.004), and a history of transient focal neurologic episodes (OR: 11.08; 95% CI: 3.49–35.19; p ,
0.001) were independently associated with cSS. However, cSS occurred in 17 of 48 patients with
probable CAA (35.4%; 95% CI: 22.2%–50.5%) without chronic lobar ICH.
Conclusions: cSS (particularly if disseminated) is a commonand characteristic feature ofCAA.Chronic
lobar ICH is an independent risk factor for cSS, but the causal direction and mechanism of association
are uncertain. Hemorrhage into the subarachnoid space, independent of previous (chronic) lobar ICH,
must also contribute to cSS in CAA. Transient focal neurologic episodes are the strongest clinical
marker of cSS. Neurology 2013;81:626–632
GLOSSARY
CAA 5 cerebral amyloid angiopathy; CI 5 confidence interval; CMB 5 cerebral microbleed; cSAH 5 convexity subarachnoid
hemorrhage; cSS 5 cortical superficial siderosis; FLAIR 5 fluid-attenuated inversion recovery; ICH 5 intracerebral hemor-
rhage; OR 5 odds ratio; T2*-GRE 5 T2*-weighted gradient recalled echo.
Sporadic cerebral amyloid angiopathy (CAA) is a common age-related small-vessel disease
caused by progressive deposition of amyloid-b in the walls of small arteries, arterioles, and
capillaries in the cerebral cortex and overlying leptomeninges.1 CAA is most often recognized
in life by symptomatic lobar intracerebral hemorrhage (ICH) in elderly patients.1–3 CAA is also
associated with characteristic MRI findings including lobar cerebral microbleeds (CMBs) and
white matter hyperintensities (leukoaraiosis).1,4
Recent studies have identified cortical superficial siderosis (cSS) as another manifestation of
CAA.5–8 In CAA, cSS has a characteristic predilection for the cerebral convexities, reflecting linear
blood residues in the superficial layers of the cerebral cortex or in the subarachnoid space.8–10 cSSmay
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have clinical relevance as an important cause of
transient focal neurologic episodes (sometimes
called “amyloid spells”),11,12 and a potential
“warning sign” for future symptomatic ICH.13
Although cSS is a promising diagnostic neu-
roimaging marker of CAA,8 the strength of the
association and underlying mechanisms have not
been systematically studied. In the present study,
we therefore sought to determine the prevalence
and extent of cSS in a European multicenter
cohort of patients with clinical-radiologic proba-
ble CAA, and investigate its associations with
other imaging findings including CMBs, white
matter changes, and ICH.We hypothesized that
cSS 1) is common in subjects with probable
CAA, and more prevalent compared to compar-
ison subjects with other spontaneous ICH not
attributed to probable CAA, and 2) is associated
with other hemorrhagic manifestations of CAA
(lobar ICH and lobar CMBs).
METHODS Study population. We included consecutive
patients diagnosed with probable CAA (according to the original Bos-
ton criteria,14 i.e., not including cSS as a criterion; see below) at 4
stroke centers over defined time periods (figure e-1 on the Neurology®
Web site at www.neurology.org). At participating centers, MRI
scanning is a routine investigation for cases of suspected CAA,
unless there are contraindications. Essential inclusion criteria for the
main CAA case groupwere 1) probable or pathologically verified CAA,
defined according to the Boston criteria,14 including lobar CMBs, but
not cSS; and 2) available MRI sequences of adequate quality including
T2*-weighted gradient recalled echo (T2*-GRE) and fluid-attenuated
inversion recovery (FLAIR) MRI sequences. Cases defined as possible
CAA according to the Boston criteria14 (i.e., single lobar ICH without
lobar microbleeds) were included in one of the comparison groups (see
next paragraph).
As comparison groups, we included patients with other sympto-
matic, spontaneous ICH not fulfilling the Boston criteria for probable
CAA, seen in the 4 stroke centers over the same time period, with
available MRI scans of adequate quality including T2*-GRE and
FLAIR sequences. Cases were systematically and consecutively ascer-
tained using multiple overlapping methods from prospective clinical
and radiologic databases. The 2 non-CAA comparison groups were as
follows: a) single lobar ICH (without any CMBs) and mixed (deep
and lobar) hemorrhages (including any combination of ICH or
CMBs), which we subsequently refer to as “single lobar ICH and
mixed hemorrhages”; and b) strictly deep hemorrhages (including
ICH and CMBs in the basal ganglia and brainstem).
In total, 149 subjects were excluded from our study because
MRI scans were unavailable (figure e-1); those excluded were not
significantly different from those included in sex, age, or measures
of stroke severity (all p values .0.10; figure e-1).
Standard protocol approvals, registrations, and patient
consents. The study received ethical approval by the National Hos-
pital for Neurology and Neurosurgery and Institute of Neurology
Joint Research Ethics Committee, the Commission d’Ethique Bio-
medicale Hospitalo Facultaire of the Faculte de Medicine (Universite
Catholique de Louvain), and the Comite d’ethique medicale of the
CHU Mont Godinne UCL.
Data collection. Demographic and clinical information was obtained
from prospective databases and by medical records review using stan-
dardized data collection forms. Hypertension was defined as a history
of hypertension, taking antihypertensive treatment, or documented
elevated blood pressure (systolic .150 or diastolic .95 mm Hg)
before admission; diabetes as ongoing use of a hypoglycemic agent;
and smoking as history of tobacco use before admission. In patients
with probable CAA, a clearly documented history of transient (#24
hours), fully resolving, focal neurologic episodes with no known
alternative explanation other than CAA (e.g., structural brain lesion,
atrial fibrillation, or extracranial or intracranial stenosis) was ascer-
tained by review of medical records.
MRI acquisition and analysis. The MRI protocol was similar in
each hospital. Imaging was at 1.5-tesla field strength for all patients
and included T1-weighted, T2-weighted, FLAIR, T2*-GRE (slice
thickness 5 mm, repetition time 500–1,000 milliseconds, echo time
40/26/15/50–70 milliseconds), and diffusion-weighted imaging
sequences. Images were reviewed blinded to clinical data. Hemorrhagic
lesions,4,8,15,16 ischemic lesions (chronic or acute),17 and white matter
hyperintensities (leukoaraiosis)18 were recorded according to predefined
standardized criteria. CMBs were evaluated on T2*-GRE images.4,16
Prior symptomatic ICH was defined as a symptomatic stroke syn-
drome associated with imaging evidence of a corresponding “macro”
ICH (.5 mm in diameter on T2*-GRE).15 Asymptomatic prior ICH
(.5mm in diameter on T2*-GREMRI) was also noted: chronic ICH
was defined on neuroimaging as ICHwith no acute bleeding identified
on either CT orMRI scans. Acute convexity subarachnoid hemorrhage
(cSAH) was defined as linear hypointensity in the subarachnoid space
affecting one or more cortical sulci of the cerebral convexities on T2*-
GRE sequences with corresponding hyperintensity in the subarachnoid
space on T1-weighted or FLAIR images. cSS was defined as linear
residues of chronic blood products in the superficial layers of the cere-
bral cortex showing a characteristic “gyriform” pattern of low signal on
T2*-GRE images, without corresponding hyperintense signal on
T1-weighted or FLAIR images. We did not include cSS if it was
contiguous with any ICH. The distribution of cSS and acute cSAH
was classified as focal (restricted to #3 sulci) or disseminated ($4
sulci).8 We also noted whether cSS was contralateral or ipsilateral to
any chronic ICH. Using a sample of MRI scans from patients with
probable CAA (n 5 48) and control, non-CAA cases (n 5 27), the
interrater agreement for the presence or absence of cSS was 93.3%
(Cohen k5 0.85) and for cSS categories was 95.1% (weighted Cohen
k 5 0.86). White matter hyperintensities (leukoaraiosis) were assessed
with the 4-step simplified Fazekas Rating Scale, from 0 to 3 (0 5 no
lesions; 1 5 focal lesions; 2 5 early confluent; 3 5 confluent).18
Statistical analysis. We compared demographic, clinical, and
imaging characteristics of patients with probable CAA, with vs
without cSS. Both binary and ordinal logistic regression analyses
were used to identify predictors of cSS (cSS presence and cSS
extent, respectively). Multivariable analysis was adjusted for age,
lobar CMBs (used as a categorical variable: 0, 1, 2–4, and .4
CMBs), presence of chronic lobar ICH, and history of transient
focal neurologic episodes, based on the results of univariable anal-
ysis, plus other biologically plausible confounders. As a sensitivity
analysis, we repeated these analyses with the addition of hyperten-
sion in our multivariable regression models. Because the results of
binary and ordinal logistic regression analyses were consistent, we
present only the results of the binary logistic regression analysis. A
p value #0.05 was considered to be statistically significant. Data
were missing in less than 5% of participants; these cases were
excluded from univariable and multivariable analyses that
included a missing variable of interest. For the main multivariable
model presented, there were no missing data. All statistical
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analyses were performed using STATA software (version 11.2;
StataCorp, College Station, TX).
RESULTS The final cohort consisted of 209 patients:
120 patients with probable CAA (9 with supportive
pathology) based on the Boston criteria and 89 patients
with other ICH not fulfilling the Boston criteria for
probable CAA, forming 2 comparison groups—67 pa-
tients with a single lobar ICH or mixed (lobar and
deep) hemorrhages, and 22 patients with strictly deep
hemorrhages (table 1).
cSS was detected in 48 of 120 (40%; 95% confi-
dence interval [CI]: 31.2%–49.3%) patients with prob-
able CAA, compared with 10 of 67 (14.9%; 95% CI:
7.4%–25.7%) of the patients with a single lobar ICH or
mixed (lobar and deep) hemorrhages, and only 1 of 22
(4.6%) patients with strictly deep hemorrhages (p ,
0.001 for trend) (table 1 and figure 1). Within the single
lobar ICH or mixed hemorrhage group, cSS was found
in 2 of 33 (6.1%) patients with single lobar ICH and no
CMBs, 2 of 11 (18%) patients with lobar ICH and deep
or mixed CMBs, and 3 of 17 (18%) patients with deep
ICH and lobar or mixed CMBs (see table e-1 for the
frequency of cSS in detailed patient subgroups). Dissem-
inated cSS was observed in 29 of 120 (24.2%; 95% CI:
16.8%–32.8%) patients with probable CAA but in none
of the other 89 patients not fulfilling the original Boston
criteria for probable CAA (p, 0.001). In patients with
single lobar ICH or mixed hemorrhages, cSS (10 of 67)
was always focal; of these 10 patients with cSS, 7 (70%)
had lobar CMBs (table e-2).
Thirty-one of the 48 patients with probable CAA and
cSS had chronic lobar ICH; the cSS was contralateral to
the ICH or bilateral in 24 (87.4%) of these patients and
restricted to the hemisphere ipsilateral to chronic lobar
ICH in only 7 patients (22.6%) (i.e., in most cases,
cSS was present distant from any chronic lobar ICH).
In 17 of the 48 patients with probable CAA and cSS
(35%), there was no evidence of chronic lobar ICH. Rep-
resentative examples of cSS are shown in figure 2.
Within the probable CAA group, patients with
cSS were older and less often hypertensive compared
Table 1 Characteristics of patients with probable CAA and our comparison patient groups with spontaneous
symptomatic ICH not fulfilling the Boston criteria for probable CAA: “Single lobar ICH and mixed
hemorrhages” and “strictly deep hemorrhages”a
Characteristics Probable CAA (n 5 120)
Comparison groups not fulfilling criteria for probable CAA
Single lobar ICH/mixed deep
and lobar hemorrhages (n 5 67)
Strictly deep
hemorrhages (n 5 22)
Age, y 71.8 (70–73.5) 72.6 (61.3–75.3) 61.2 (58.5–71.8)
Male 67 (55.8) 35 (52.3) 15 (68.2)
Hypertension 72 (64.3) 48 (71.6) 21 (99.5)
Taking antithrombotics 25 (22.1) 24 (35.8) 7 (31.8)
Any symptomatic ICH 104 (86.7)b 67 (100) 22 (100)
Cortical superficial siderosis 48 (40) 10 (14.9) 1 (4.6)
Focal, £3 sulci 19 (15.8) 10 (14.9) 1 (4.6)
Disseminated, ‡4 sulci 29 (24.2) 0 (0) 0 (0)
Acute cSAH 15 (12.5) 3 (4) 0 (0)
Abbreviations: CAA 5 cerebral amyloid angiopathy; cSAH 5 convexity subarachnoid hemorrhage; ICH 5 intracerebral
hemorrhage.
aData are mean (95% confidence interval) or n (%).
bOne hundred four of the patients with probable CAA were admitted for spontaneous lobar ICH, 8 with transient focal
neurologic episodes, 2 because of cognitive decline, 2 with acute cSAH, and 2 because of an ischemic stroke.
Figure 1 Prevalence (%, 95% CI) of cSS in different groups
The prevalence of cortical superficial siderosis (cSS) is significantly higher in patients with
probable cerebral amyloid angiopathy (CAA) compared with the comparison groups (single
lobar intracerebral hemorrhage [ICH] and mixed hemorrhages, and strictly deep hemor-
rhages). The p value for trend calculated using x2 test. CI 5 confidence interval.
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with patients without cSS (table 2). Patients with
cSS more often had a history of transient focal neu-
rologic episodes and chronic lobar ICH on MRI
than patients without cSS. However, we found no
association between the presence of cSS and acute
lobar ICH, lobar CMBs, or white matter hyperin-
tensity severity.
In univariable logistic regression analysis, factors
associated with cSS were age, history of transient focal
neurologic episodes, and chronic lobar ICH (table
e-3). Hypertension showed a negative association
with cSS. In multivariable logistic regression analysis,
age, presence of chronic lobar ICH, and history of
transient focal neurologic episodes were indepen-
dently associated with cSS, after adjusting for lobar
CMBs (table 3). These results remained consistent
after additional adjustment for hypertension and
acute cSAH (data not shown). The results of cSS
predictors in ordinal logistic regression (i.e., predic-
tors of cSS extent: no cSS vs focal vs disseminated)
were consistent and of similar effect size.
DISCUSSION To our knowledge, this multicenter
retrospective study is the first systematic survey of
the prevalence and clinical-radiologic associations of
cSS in patients with probable sporadic CAA (diag-
nosed by the original Boston criteria) compared to
those with ICH not fulfilling these criteria. A previ-
ous study investigated the presence of cSS in patients
diagnosed with CAA on histopathology8: cSS was
detected in 60.5% of patients with histopathologically
proven CAA (n 5 38; mean age 70 years) compared
with none of the controls with histopathologically
proven non-CAA ICH (n 5 22; mean age 54 years).8
The authors suggested that cSS might be helpful for the
clinical diagnosis of CAA.8 cSS has also been found in
patients with hereditary cerebral hemorrhage with amy-
loidosis–Dutch type, a distinct genetic type of CAA, and
always in the direct vicinity of a lobar ICH or a CMB.19
Our findings strengthen the hypothesis that cSS (espe-
cially if disseminated) is a characteristic neuroimaging
marker for CAA. We noted cSS in 40% of patients with
probable CAA, disseminated cSS only in patients with
probable CAA, and found that cSS is much rarer (prev-
alence less than 5%) in patients with a “strictly deep”
pattern of ICH than with probable CAA. We also
detected cSS in 15% of patients with a single lobar ICH
or mixed (lobar and deep) hemorrhages; however, in
most of these patients with mixed hemorrhages, lobar
CMBs were also present, suggesting that they might in
fact harbor some degree of CAA pathology.
Among patients with a single lobar ICH and no
CMBs (i.e., “possible CAA” according to the original
Boston criteria14), the prevalence of cSS was also very
low (6%). In a validation of these criteria, 16 of 26
patients (62%) classified as possible CAA had patholog-
ically confirmed CAA,14 but only 11 of the pathologically
diagnosed patients had T2*-GRE imaging, limiting the
generalizability of the findings to current cohorts (includ-
ing our study), in which such imaging is now routine. In
another validation study of the Boston criteria, using
T2*-weighted gradient echo MRI in a hereditary
Dutch-type CAA population, all patients with lobar
Figure 2 T2*-GRE and FLAIR MRIs of 2 patients with probable CAA and a
patient with mixed deep and lobar hemorrhages
(A) Patient with probable cerebral amyloid angiopathy (CAA) and an acute right frontal intra-
cerebral hemorrhage (ICH) and multifocal cortical superficial siderosis (cSS) in the left hem-
isphere. Multiple lobar cerebral microbleeds (CMBs) are also present, sometimes close to the
cSS. (B) Patient with probable CAA with focal, bilateral cSS and lobar CMBs, in whom no
ICHs were present. (C) Patient with a mixed pattern of bleeds (ICH and CMBs) not fulfilling
the Boston criteria for CAA: note the focal cSS in the left hemisphere (arrow) and the lobar
CMBs in close vicinity to the cSS (arrowheads). FLAIR5 fluid-attenuated inversion recovery;
T2*-GRE 5 T2*-weighted gradient recalled echo.
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ICH also had CMBs.19 Our data suggest that further
pathologic correlation is required to determine the prev-
alence of pathologically confirmed CAA in patients with
a single lobar ICH (and no CMBs or cSS) on
appropriate blood-sensitive MRI sequences. Further
studies with histopathologic confirmation or in vivo
amyloid imaging20 will also help to determine whether
cSS is a useful diagnostic feature of CAA in patients with
mixed patterns of hemorrhage.
In the healthy population-based Rotterdam Scan
Study, cSS was found in 0.7% (7/1,062) of elderly indi-
viduals (mean age 69.6 years), all of whom had lobar
CMBs (6 had strictly lobar CMBs, 5 of whom had mul-
tiple CMBs) in close vicinity to the cSS.10 In agreement
with our findings, the mean age of persons with cSS was
higher than in those without cSS (mean age 79.9 vs 69.6
years; p, 0.001), and also compared with persons who
had CMBs but no cSS (mean age 71.8 years).10 Because
the severity of CAA is age-related,1,3 these findings,
together with our data showing an association of cSS
with chronic ICH, suggest that cSS might be a marker
Table 2 Characteristics and comparison of CAA patients with and without cSS
Characteristics All probable CAA (n 5 120) cSS (1) (n 5 48) cSS (2) (n 5 72) p Valuea
Age, y, mean (95% CI) 71.8 (70–73.5) 74.8 (72.3–77.3) 69.7 (67.4–72.1) 0.005
Male, n (%) 67 (55.8) 25 (52.1) 42 (58.3) 0.499
Hypertension, n (%)b 72 (64.3) 20 (46.5) 52 (75.4) 0.002
Taking antithrombotics, n (%)b 25 (22.1) 9 (20.9) 16 (22.9) 0.811
History of symptomatic ICH, n (%)b 46 (40.7) 18 (41.9) 28 (40) 0.845
History of TFNE, n (%) 26 (21.7) 19 (39.6) 7 (9.7) ,0.001
Neuroimaging characteristics
Chronic lobar ICH, n (%) 61 (51.3) 31 (64.6) 30 (42.3) 0.017
Acute lobar ICH, n (%) 57 (48.3) 26 (54.2) 31 (44.3) 0.291
Acute ischemic lesions, n (%) 20 (18.7) 10 (23.3) 10 (15.6) 0.321
No. of CMBs, median (IQR) 4 (2–13.5) 4.5 (1–10.5) 4 (2–15.5) 0.147
Lobar CMBs, n (%)
0 13 (10.8) 9 (18.8) 4 (5.6) —
1 16 (13.3) 7 (14.6) 9 (12.5) —
2–4 34 (28.3) 8 (16.7) 26 (36.1) —
‡5 57 (47.5) 24 (50) 33 (45.8) —
Acute cSAH, n (%) 15 (12.5) 9 (18.8) 6 (8.3) 0.091
Leukoaraiosis —
Fazekas category, n (%) —
Absent 19 (16.1) 8 (17) 11 (15.5) 0.652c
Mild 36 (30.5) 17 (36.2) 19 (26.8) —
Moderate 41 (34.8) 15 (31.9) 26 (35.6) —
Severe 22 (18.6) 7 (14.9) 15 (21.1) —
Moderate to severe leukoaraiosis, n (%) 63 (53.4) 22 (46.8) 41 (57.6) 0.244
Abbreviations: CAA 5 cerebral amyloid angiopathy; CI 5 confidence interval; CMB 5 cerebral microbleed; cSAH 5 con-
vexity subarachnoid hemorrhage; cSS 5 cortical superficial siderosis; ICH 5 intracerebral hemorrhage; IQR 5 interquartile
range; TFNE 5 transient focal neurologic episodes.
a The p values refer to differences between CAA patients with vs without cSS, using x2 tests and the Fisher exact test for
categorical variables, and 2-sample t tests or Mann-Whitney U tests depending on the distribution of continuous variables.
b There were 10 patients with missing data for one or more of these variables: hypertension (n 5 9), taking antithrombotics
(n 5 8), and history of symptomatic ICH (n 5 7).
c The p value for trend.
Table 3 Multivariable regression analysis showing the factors associated with
cortical superficial siderosis in patients with probable cerebral amyloid
angiopathya
OR (95% CI) p Value
Age 1.09 (1.03–1.15) 0.002
Lobar CMBs (for each category increase) 0.77 (0.50–1.21) 0.260
Chronic lobar ICH 3.94 (1.54–10.08) 0.004
History of transient focal neurologic episodes 11.08 (3.49–35.19) ,0.001
Abbreviations: CI 5 confidence interval; CMB 5 cerebral microbleed; ICH 5 intracerebral
hemorrhage; OR 5 odds ratio.
a The model remains consistent when history of hypertension and acute convexity suba-
rachnoid hemorrhage (%) are included.
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of more advanced CAA, but this also requires pathologic
confirmation, with standardized grading of CAA severity.
Experimental studies confirm that repeated bleed-
ing into the subarachnoid space leads to subpial hemo-
siderin deposition.21 There are thus at least 2 possible
pathophysiologic mechanisms that could lead to cSS
deposition in CAA: a) repeated episodes of hemorrhage
from brittle superficial cortical or leptomeningeal
CAA-affected vessels into the subarachnoid space
(independent of lobar ICH); and b) leakage from a
previous lobar ICH (or superficial lobar CMBs) into
the subarachnoid space. Our observation of cSS in 17
patients without chronic lobar ICH, and even in those
with chronic lobar ICH mostly distant from the ICH
(in nearly 90% of cases in the contralateral hemisphere
or bilaterally), favors a contribution from direct hem-
orrhage into the subarachnoid space, independent of
lobar ICH. This implies that cSS may arise indepen-
dently of known characteristic imaging features of
CAA (lobar ICH and CMBs), supporting its role as
an independent diagnostic marker; further studies are
needed to confirm the value of cSS in improving the
sensitivity of in vivo CAA diagnosis.
Perhaps surprisingly, we did not find any association
between lobar CMBs and cSS, which may reflect selec-
tion bias toward generally advanced disease with high
lobar CMBs prevalence in our cohort. Nevertheless, in
some cases, cSS was observed close to one or more lobar
CMBs (see, e.g., figure 2), suggesting that leakage from
very superficial CMBs may also be a mechanism of cSS.
Another interpretation of the association between cSS
and lobar ICH is that cSS precedes lobar ICH. Although
our cross-sectional data cannot confirm this hypothesis,
some recent data support this explanation. A retrospec-
tive study of 51 patients with cSS attributable to possible
or probable CAA found that after a median 35.3
months’ follow-up, 47.1% of the patients had new radi-
ologic ICH or cSAH, often at the site of pre-existing
siderosis,13 providing preliminary evidence that cSS her-
alds a high risk of future ICH. A small neuropathologic
series of 6 autopsy cases of subcortical hematoma caused
by CAA showed that at least in some cases the primary
hemorrhage appeared to originate from the subarachnoid
space.22 Further prospective studies are urgently required
to determine the risk of future intracranial bleeding asso-
ciated with cSS in CAA.
Our study confirms a strong independent associa-
tion of cSS with transient focal neurologic episodes
(sometimes called “amyloid spells”23), which are
increasingly recognized in CAA and can resemble
TIAs, migraine auras, or focal seizures.11,12,23 Such
attacks could plausibly be caused by disruption
of cortical function due to cSS, for example by super-
ficial cortical hemosiderin deposition inducing focal
seizures or cortical spreading depression.11,23–25 CAA-
related transient focal neurologic episodes are
associated with a high early risk of symptomatic lobar
ICH (24.5% [95% CI: 15.8%–36.9%] at 8 weeks)11;
cSS may be one mechanism underpinning this
increased clinical risk, reflecting focally active CAA
near the cortical surface.26
Our study has several strengths, including the system-
atic evaluation of MRI scans by trained raters using vali-
dated scales for a range of imaging markers of small-vessel
disease. A limitation is the lack of pathologic confirmation
of the CAA pathology. In view of the imperfect specificity
of the Boston criteria, especially for the “possible CAA”
category,14 we focused on patients fulfilling the criteria for
probable CAA, for which the specificity is between 82%
and 100%.14,19 Limitations of our study include the ret-
rospective design, the variation in inception point of the
disease at inclusion, and the potential of bias in our sam-
ple because MRIs were performed as part of routine clin-
ical care, tending to exclude more severe cases of CAA
and ICH.
Our study indicates that cSS (particularly if dissemi-
nated) is a characteristic neuroimaging feature of CAA.
Chronic lobar ICH is an independent risk factor for
cSS, but the causal direction and mechanism of the asso-
ciation is uncertain: although leakage from previous lobar
ICH into the subarachnoid space may lead to cSS, it is
also possible that cSS heralds an increased risk of future
lobar ICH. Further prospective studies are needed to
clarify how cSS relates to future ICH risk, which may
have important clinical relevance, for example regarding
antithrombotic treatment. Our results also show that
hemorrhage into the subarachnoid space, independent
of lobar ICH, must also contribute to cSS in CAA, sug-
gesting that cSS should be considered an additional neu-
roimaging marker of CAA-related hemorrhage.
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